Aprea Therapeutics, Inc. (APRE) Financials
APRE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 25.8 million | 5.5 million |
2023-06-30 | 28.7 million | 5.3 million |
2023-03-31 | 32.0 million | 5.5 million |
2022-12-31 | 30.2 million | 4.5 million |
APRE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.3 million | 76031 |
2023-06-30 | -3.2 million | 269323 |
2023-03-31 | -3.0 million | 16244 |
2022-12-31 | -4.0 million | 57355 |
APRE Net Income
No data available :(
APRE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 25.4 million | - | - |
2023-06-30 | 27.7 million | - | - |
2023-03-31 | 31.0 million | - | - |
2022-12-31 | 28.8 million | - | - |
APRE Shares Outstanding
APRE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 84079 | 2.1 million | 1.7 million | - |
2023-06-30 | - | 2.2 million | 1.7 million | - |
2023-03-31 | - | 1.3 million | 3.4 million | - |
2022-12-31 | - | 531406 | 2.1 million | - |
APRE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 319468 | - |
2023-06-30 | 249688 | - |
2023-03-31 | - | 410 |
2022-12-31 | - | - |
APRE
Price: $5.20
52 week price:
Earnings Per Share: 12.31 USD
P/E Ratio: 0.42
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 118567
Market Capitalization: 23.2 million